These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22396171)

  • 1. Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities.
    Wu X; Li Y
    Adv Exp Med Biol; 2012; 728():195-213. PubMed ID: 22396171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity.
    Harmer NJ; Pellegrini L; Chirgadze D; Fernandez-Recio J; Blundell TL
    Biochemistry; 2004 Jan; 43(3):629-40. PubMed ID: 14730967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mini-review: endocrine actions of fibroblast growth factor 19.
    Jones S
    Mol Pharm; 2008; 5(1):42-8. PubMed ID: 18179175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF19 and cancer.
    Lin BC; Desnoyers LR
    Adv Exp Med Biol; 2012; 728():183-94. PubMed ID: 22396170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural biology of the FGF19 subfamily.
    Beenken A; Mohammadi M
    Adv Exp Med Biol; 2012; 728():1-24. PubMed ID: 22396159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
    Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD
    Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Saga of Endocrine FGFs.
    Phan P; Saikia BB; Sonnaila S; Agrawal S; Alraawi Z; Kumar TKS; Iyer S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.
    Wu X; Ge H; Lemon B; Vonderfecht S; Weiszmann J; Hecht R; Gupte J; Hager T; Wang Z; Lindberg R; Li Y
    J Biol Chem; 2010 Feb; 285(8):5165-70. PubMed ID: 20018895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in
    Hansen AMK; Vienberg SG; Lykkegaard K; Zhao X; Tingqing G; Han D; Zhang X; Thøgersen H; Sass-Ørum K; Tagmose T; Raun K; Andersen B
    Biochem J; 2018 Sep; 475(18):2985-2996. PubMed ID: 30127091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiology of FGF15/19.
    Jones SA
    Adv Exp Med Biol; 2012; 728():171-82. PubMed ID: 22396169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
    Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability.
    Niu J; Zhao J; Wu J; Qiao G; Gu J; Zhou C; Li Q; Ying L; Wang D; Lin H; Li X; Mohammadi M; Huang Z
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29025-29034. PubMed ID: 33144503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
    Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J
    Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FGF metabolic axis.
    Li X
    Front Med; 2019 Oct; 13(5):511-530. PubMed ID: 31495905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.
    Desnoyers LR; Pai R; Ferrando RE; Hötzel K; Le T; Ross J; Carano R; D'Souza A; Qing J; Mohtashemi I; Ashkenazi A; French DM
    Oncogene; 2008 Jan; 27(1):85-97. PubMed ID: 17599042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target.
    Liu WY; Xie DM; Zhu GQ; Huang GQ; Lin YQ; Wang LR; Shi KQ; Hu B; Braddock M; Chen YP; Zheng MH
    Expert Opin Ther Targets; 2015 May; 19(5):675-85. PubMed ID: 25547779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic utilities of fibroblast growth factor 19.
    Wu X; Li Y
    Expert Opin Ther Targets; 2011 Nov; 15(11):1307-16. PubMed ID: 21961833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
    Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C
    FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF19-FGFR4 signaling elaborates lens induction with the FGF8-L-Maf cascade in the chick embryo.
    Kurose H; Okamoto M; Shimizu M; Bito T; Marcelle C; Noji S; Ohuchi H
    Dev Growth Differ; 2005 May; 47(4):213-23. PubMed ID: 15921496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different roles of N- and C- termini in the functional activity of FGF21.
    Micanovic R; Raches DW; Dunbar JD; Driver DA; Bina HA; Dickinson CD; Kharitonenkov A
    J Cell Physiol; 2009 May; 219(2):227-34. PubMed ID: 19117008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.